A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06)

被引：0
|
作者：
Hideki Takeuchi
Hiroyuki Takei
Kazushige Futsuhara
Takashi Yoshida
Makoto Kojima
Toshihiro Kai
Toshio Tabei
机构：
[1] Saitama Medical University International Medical Center,Department of Breast Oncology
[2] Saitama Cancer Center,Division of Breast Surgery
[3] Jichi Medical University,Department of Surgery, Saitama Medical Center
[4] Dokkyo Medical University,Breast Center, Koshigaya Hospital
[5] Shintoshin Ladies’ Mammo Clinic,Division of Breast Oncology
[6] Saitama Cancer Center,undefined
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Adjuvant treatment; Anastrozole; Bone fracture; Bone mineral density; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：68 / 73
页数：5
相关论文
共 50 条
  • [1] A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06)
    Takeuchi, Hideki
    Takei, Hiroyuki
    Futsuhara, Kazushige
    Yoshida, Takashi
    Kojima, Makoto
    Kai, Toshihiro
    Tabei, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 68 - 73
  • [2] Bone effects of anastrozole in Japanese postmenopausal breast cancer patients: results of a two year follow-up multicenter prospective study (SBCCSG-06)
    Takeuchi, H.
    Futsuhara, K.
    Yoshida, T.
    Takei, H.
    Kojima, M.
    Inoue, K.
    Kurosumi, M.
    Kai, T.
    Tabei, T.
    EJC SUPPLEMENTS, 2010, 8 (03): : 165 - 165
  • [3] Multicenter prospective study of bone effects on anastrozole in Japanese postmenopausal patients with breast cancer - results of one year follow-up (SBCCSG 06;UMIN 514)
    Futsuhara, K.
    Tabei, T.
    Kojima, M.
    Yoshida, T.
    Takei, H.
    Nakano, S.
    Inoue, K.
    Takeuchi, H.
    Miyake, H.
    Kimizuka, K.
    Kuroda, T.
    Yamada, H.
    Saito, T.
    Yamashita, S.
    Hata, S.
    Uchida, Y.
    Kai, T.
    Kurosumi, M.
    Arisawa, F.
    BREAST, 2009, 18 : S59 - S59
  • [4] Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01)
    Sato, K
    Inoue, K
    Saito, T
    Kai, T
    Mihara, H
    Okubo, K
    Koh, J
    Mochizuki, H
    Tabei, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (08) : 371 - 376
  • [5] Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 155 - 156
  • [6] Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)
    Takei, Hiroyuki
    Suemasu, Kimito
    Inoue, Kenichi
    Saito, Tsuyoshi
    Okubo, Katsuhiko
    Koh, Junichi
    Sato, Kazuhiko
    Tsuda, Hitoshi
    Kurosumi, Masafumi
    Tabei, Toshio
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (01) : 87 - 94
  • [7] Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)
    Hiroyuki Takei
    Kimito Suemasu
    Kenichi Inoue
    Tsuyoshi Saito
    Katsuhiko Okubo
    Junichi Koh
    Kazuhiko Sato
    Hitoshi Tsuda
    Masafumi Kurosumi
    Toshio Tabei
    Breast Cancer Research and Treatment, 2008, 107 : 87 - 94
  • [8] Multicenter phase II study of weekly paclitaxel followed by doxorubicin plus paclitaxel as neoadjuvant chemotherapy for triple negative breast cancer (SBCCSG#12, Saitama Breast Cancer Clinical Study Group, Japan)
    Nagai, S. E.
    Inoue, K.
    Futsuhara, K.
    Saito, T.
    Sakurai, T.
    Takei, H.
    Kai, T.
    Kurosumi, M.
    Tabei, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S468 - S469
  • [9] Factors influencing on discontinuation of adjuvant anastrozole in postmenopausal Japanese breast cancer patients: Results from a prospective multicenter cohort study of patient-reported outcomes
    Egawa, Chiyomi
    Takao, Shintaro
    Yamagami, Kazuhiko
    Miyashita, Masaru
    Baba, Masashi
    Ichii, Shigetoshi
    Konishi, Muneharu
    Kikawa, Yuichiro
    Minohata, Junya
    Okuno, Toshitaka
    Miyauchi, Keisuke
    Wakita, Kazuyuki
    Suwa, Hirofumi
    Hashimoto, Takashi
    Nishino, Masayuki
    Matsumoto, Takashi
    Hidaka, Toshiharu
    Konishi, Yutaka
    Sakoda, Yoko
    Miya, Akihiro
    Kishimoto, Masahiro
    Nishikawa, Hidefumi
    Kono, Seishi
    Kokufu, Ikuo
    Sakita, Isao
    Kitatsuji, Koushiro
    Oh, Koushi
    Miyoshi, Yasuo
    CANCER RESEARCH, 2015, 75
  • [10] PROACT: A randomised study comparing anastrozole with tamoxifen as neoadjuvant and adjuvant treatment in postmenopausal women with locally advanced breast cancer - a Japanese subgroup analysis
    Imoto, S.
    Takatsuka, Y.
    Fujiwara, Y.
    Inaji, H.
    Ikeda, T.
    Cataliotti, L.
    Buzdar, A.
    Noguchi, S.
    BREAST, 2009, 18 : S64 - S64
12345